NCT00596219View on ClinicalTrials.gov

Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

December 31, 2003

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2010

Conditions
SQUAMOUS CELL CARCINOMA
Interventions
DRUG

celecoxib

celecoxib

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT00596219 - Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma | Biotech Hunter | Biotech Hunter